Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zevra Therapeutics (ZVRA) Intangibles (2023 - 2025)

Historic Intangibles for Zevra Therapeutics (ZVRA) over the last 3 years, with Q3 2025 value amounting to $6.7 million.

  • Zevra Therapeutics' Intangibles fell 9045.86% to $6.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.7 million, marking a year-over-year decrease of 9045.86%. This contributed to the annual value of $69.0 million for FY2024, which is 33.8% down from last year.
  • Zevra Therapeutics' Intangibles amounted to $6.7 million in Q3 2025, which was down 9045.86% from $7.1 million recorded in Q2 2025.
  • Zevra Therapeutics' Intangibles' 5-year high stood at $70.6 million during Q3 2024, with a 5-year trough of $6.7 million in Q3 2025.
  • Moreover, its 3-year median value for Intangibles was $67.5 million (2024), whereas its average is $53.0 million.
  • Its Intangibles has fluctuated over the past 5 years, first plummeted by 33.8% in 2024, then crashed by 9045.86% in 2025.
  • Over the past 3 years, Zevra Therapeutics' Intangibles (Quarter) stood at $69.2 million in 2023, then fell by 0.34% to $69.0 million in 2024, then tumbled by 90.24% to $6.7 million in 2025.
  • Its Intangibles stands at $6.7 million for Q3 2025, versus $7.1 million for Q2 2025 and $67.4 million for Q1 2025.